Bioharvest Sciences Inc (BHSC.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 385 | 407 | 399 | 341 | 351 |
| Accounts receivable | 33 | -242 | -419 | 201 | -507 |
| Other Working Capital | -768 | 343 | 11 | -379 | -24 |
| Other Operating Activity | -1,741 | -1,964 | -1,418 | -2,552 | -1,579 |
| Operating Cash Flow | $-2,091 | $-1,456 | $-1,427 | $-2,389 | $-1,759 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -425 | -592 | -684 | -393 | -512 |
| Other Investing Activity | 0 | 0 | 4 | -7 | 40 |
| Investing Cash Flow | $-425 | $-592 | $-680 | $-400 | $-472 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 3,343 | 3,314 | 0 |
| Debt Repayment | -424 | -256 | -221 | -860 | -164 |
| Other Financing Activity | 10,160 | 2,642 | 0 | 0 | 0 |
| Financing Cash Flow | $9,736 | $2,386 | $3,122 | $2,454 | $-164 |
| Exchange Rate Effect | 19 | -12 | -4 | -43 | -5 |
| Beginning Cash Position | 3,727 | 3,401 | 2,390 | 2,768 | 5,168 |
| End Cash Position | 10,966 | 3,727 | 3,401 | 2,390 | 2,768 |
| Net Cash Flow | $7,220 | $338 | $1,015 | $-335 | $-2,395 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,091 | -1,456 | -1,427 | -2,389 | -1,759 |
| Capital Expenditure | -425 | -592 | -684 | -393 | -512 |
| Free Cash Flow | -2,516 | -2,048 | -2,111 | -2,782 | -2,271 |